Penicillin-resistant pneumococci in Southern Sweden, 1993-1997

Microbial Drug Resistance

Volumn 5, Issue 1, 1999, Pages 31-36

  Kamme, Carl ^a,d   Ekdahl, Karl ^b   Mölstad, Sigvard ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEPHALOSPORIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN V;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; HUMAN; MAJOR CLINICAL STUDY; PENICILLIN RESISTANCE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIA; SWEDEN;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS;

EID: 0032944862     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1999.5.31     Document Type: Article

References (19)

1. Arason, V.A., K.G. Kristinsson, J.A. Sigurdsson, G. Stefánsdóttir, S. Molstad, and S. Gudmundsson. 1996. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Br. Med. J. 313:387-391.
2. Baquero, F. 1996. Epidemiology and management of penicillin-resistant pneumococci. Curr. Opin. Infect. Dis. 9:372-379.
3. Ekdahl, K., I. Ahlinder, H.B. Hansson, E. Melander, S. Mölstad, M. Söderström, and K. Persson. 1997. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project. Clin. Infect. Dis. 25:1113-1117.
4. Ekdahl, K., H.B. Hansson, S. Mölstad, M. Söderström, M. Walder, and K. Persson. 1998. Limiting the spread of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project. Microb. Drug. Resist. 4:99-105.
5. Ekdahl, K., T. Holmdahl, M. Vejvoda, and K. Persson. 1997. Eradication of penicillin-resistant Streptococcus pneumoniae in the nasopharynx with antibiotic combinations including rifampicin: Experiences from the South Swedish Pneumococcal Intervention project. Scand. J. Infect. Dis. 29:373-375.
6. Ekdahl, K., and C. Kamme. 1994. Increasing resistance to penicillin in Streptococcus pneumoniae in Southern Sweden. Scand. J. Infect. Dis. 26:301-305.
7. Ekdahl, K., A. Mårtensson, and C. Kamme. 1998. Bacteremic pneumococcal infections in Southern Sweden 1981-1996. Trends in incidence, mortality, age-distribution, serogroups and penicillin resistance. Scand. J. Infect. Dis. 30:257-262.
8. Eliasson, I., E. Holst, S. Mölstad, and C. Kamme. 1990. Emergence and persistence of beta-lactamase producing bacteria in the upper respiratory tract in children treated with betalactam antibiotics. Am. J. Med. 88(Suppl. 5A):51-55.
9. Forsgren, A., and M. Walder. 1994. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow up study of some respiratory tract pathogens. APMIS 102:227-235.
10. Henderson, F.W., P.H. Gilligan, K. Wait, and D.A. Goff. 1988. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J. Infect. Dis. 157:256.
11. Kristinsson, K.G. 1997. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb. Drug Resist. 3:117-123.
12. Lefevre, J.C., M.A. Bertrand, and G. Faucon. 1995. Molecular analysis by pulsed field gel electrophoresis of penicillin-resistant Streptococcus pneumoniae from Toulouse, France. Eur. J. Clin. Microbiol. Infect. Dis. 14:491-497.
13. Melander, E., K. Ekdahl, H.B. Hansson, C. Kamme, M. Laurell, P. Nilsson, K. Persson, M. Söderström, and S. Mölstad. 1998. Introduction and clonal spread of penicillin- and trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae serotype 9V in southern Sweden. Microb. Drug Resist. 4:71-78.
14. National Corporation of Pharmacies. 1998. The prescription study 1993-1997. Apoteksbolaget AB, Stockholm, Sweden.
15. Olsson-Liljequist, B., L.G. Burman, I. Kallings, and the Swedish Respiratory Tract Study Group. 1992. Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: a seven year follow-up study including loracarbef. Scand. J. Infect. Dis. 24:485-493.
16. Olsson-Liljequist, B., P. Larsson, M. Walder, and H. Miörner. 1997. Antimicrobial susceptibility testing in Sweden. Scand. J. Infect. Dis. Suppl. 105:13-23.
17. Skulnick, M., G.W. Small, P. Lo, M.P. Patel, C.R. Porter, D.E. Low, S. Matsumura, and T. Mazzulli. 1995. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone. J. Clin. Microbiol. 33:2334-2337.
18. Vilhelmsson, S.E., K.G. Kristinsson, C. Kamme, and A. Tomasz. 1998. Variability of certain pneumococcal clones in Sweden. Abstract No. 1-11:30 First International Symposium on Pneumococci and Pneumococcal Diseases. Elsinore, Denmark.
19. National Corporation of Pharmacies. 1998. Yearly statistical report 1998. Apoteksbolaget AB, Stockholm, Sweden.